Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Postmenopause

Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause. 2009 Nov–Dec;16(6):1093–101.
Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the postmenopausal Health Study. Menopause. 2009 Jul–Aug;16(4):701–7.
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat. 2009 Jul;116(2):339–50.
Vitamin D insufficiency does not affect response of bone mineral density to alendronate. Osteoporos Int. 2009 Jul;20(7):1259–66.
A population-based cohort study on sun habits and endometrial cancer. Br J Cancer. 2009 Jun 23.
Secondary Causes of Low Bone Mass in Patients With Breast Cancer: A Need for Greater Vigilance. J Clin Oncol. 2009 Jun 22.
Increase of Bone Resorption and the Parathyroid Hormone in Postmenopausal Women in the Long-term after Roux-en-Y Gastric Bypass. Obes Surg. 2009 Jun 11.
The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort. Osteoporos Int. 2009 Jun 9.
Minerals and vitamins in bone health: the potential value of dietary enhancement. Br J Nutr. 2009 Jun;101(11):1581–96.
Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila Pa). 2009 Jun;2(6):598–604.
An observational study on the adherence to treatment guidelines of osteopenia. J Womens Health (Larchmt). 2009 Jun;18(6):873–81.
Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis. Osteoporos Int. 2009 Jun;20(6):943–8.
High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum. 2009 Jun;38(6):444–51.
Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int. 2009 May 9.
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009 May;64(5):559–67.
Is there any requirement for celiac disease screening routinely in postmenapausal women with osteoporosis? Rheumatol Int. 2009 May;29(7):841–5.
Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate. Thyroid. 2009 May;19(5):437–42.
Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women. BJU Int. 2009 Apr 15.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000227. Review.
The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis. J Bone Miner Metab. 2009 Apr 3.
Hip fractures in the elderly in Israel—possible impact of preventable conditions. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):182–5.
Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the Postmenopausal Health Study. Menopause. 2009 Mar 6.
The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. J Mol Endocrinol. 2009 Mar;42(3):239–47.
The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass. Acta Pharmacol Sin. 2009 Mar;30(3):372–8.
Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):495–507.
Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study. Am J Clin Nutr. 2009 Jan;89(1):323–30.
Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone. 2009 Jan;44(1):168–72.
Vitamin-d-receptor genotypes and bone-mineral density in postmenopausal women: interaction with physical activity. J Aging Phys Act. 2009 Jan;17(1):31–45.
RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. J Steroid Biochem Mol Biol. 2009 Jan;113(1–2):46–51.
Predictors of Adherence in the Women's Health Initiative Calcium and Vitamin D Trial. Behav Med. 2009 Winter;34(4):145–55.
Correlation between bone markers and bone mineral density in postmenopausal women with osteoporosis. Endocr Pract. 2008 Dec;14(9):1102–7.
25-Hydoxyvitamin D levels among healthy Saudi Arabian women. Saudi Med J. 2008 Dec;29(12):1765–8.
Effect of Roux-en Y Gastric Bypass on Bone Metabolism in Patients with Morbid Obesity: Mansoura Experiences. Obes Surg. 2008 Dec;18(12):1526–31.
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 19;100(22):1581–91.
Breast cancer prevention using calcium and vitamin D: a bright future? J Natl Cancer Inst. 2008 Nov 19;100(22):1562–4.
Dietary calcium and vitamin D intakes in childhood and throughout adulthood and mammographic density in a British birth cohort. Br J Cancer. 2008 Nov 4;99(9):1539–43.
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol. 2008 Oct 20;26(30):4875–82.
Bone metabolism in postmenopausal women with lumbar spinal stenosis: analysis of bone mineral density and bone turnover markers. Spine. 2008 Oct 15;33(22):2435–9.
Urban tropospheric ozone increases the prevalence of vitamin D deficiency among Belgian postmenopausal women with outdoor activities during summer. J Clin Endocrinol Metab. 2008 Oct;93(10):3893–9.
Health maintenance for postmenopausal women. Am Fam Physician. 2008 Sep 1;78(5):583–91.
The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecol Endocrinol. 2008 Sep;24(9):514–8.
Osteoporotic Caucasian and South Asian women: a qualitative study of general practitioners' support. J R Soc Health. 2008 Sep;128(5):263–70.
Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study. Osteoporos Int. 2008 Aug;19(8):1211–7.
Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008 Aug;88(2):500S–506S. Review.
Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr. 2008 Aug;88(2):513S–519S. Review.
Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients. Chin Med J (Engl). 2008 Jul 20;121(14):1280–4.
Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women. J Appl Physiol. 2008 Jul;105(1):274–81.
The remodeling transient and the calcium economy. Osteoporos Int. 2008 Jul;19(7):1001–9.
Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am. 2008 Jun;35(2):301–15, ix. Review.
Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin. 2008 May;24(5):1363–70. Review.
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res. 2008 May;23(5):715–20.
Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis. J Endocrinol Invest. 2008 May;31(5):416–21.
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int. 2008 May;19(5):673–9.
Influence of adjuvant pain medication on quality of life in the treatment of postmenopausal osteoporosis. Orthopade. 2008 May;37(5):435–9. In German.
Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone. 2008 May;42(5):996–1003.
Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 2007 Dec;86(6):1657–62.
Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women. Int J Vitam Nutr Res. 2007 Sep;77(5):320–5.
Correlation of plain radiographic indices of the hip with quantitative bone mineral density. Osteoporos Int. 2007 Aug;18(8):1119–26.
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1–235. Review.
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun;85(6):1586–91.
Calcium Plus Vitamin D Supplementation and the Risk of Postmenopausal Weight Gain. Arch Intern Med. 2007 May 14;167:893-902.
The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone. 2007 Apr;40(4):1041–7.
Distinct association of gene polymorphisms of estrogen receptor and vitamin D receptor with lumbar spondylosis in post-menopausal women. Eur Spine J. 2006 Oct;15(10):1521–8.
Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr. 2006 Oct;25(5):395–402.
Vitamin D status of 51–75-year-old Irish women: its determinants and impact on biochemical indices of bone turnover. Public Health Nutr. 2006 Apr;9(2):225–33.
Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 2005 Sep;98(9):667–76. Review.
A Randomized Controlled Trial of Vitamin D3 Supplementation in African American Women. Arch Intern Med. 2005 Jul 25;165:1618–1623.
Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int. 2004 Jun;15(6):447–51.
Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int. 2000;11(9):739–44.
Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999 Sep;2(3):283–91.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999 Apr 28;281(16):1505–11.
Osteoporosis in adult patients with celiac disease. Bone. 1999 Mar;24(3):249–55.
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27(4–6):815–24. Review.
Studies on the hydroxylation of vitamin D in man. Ann Med Interne (Paris). 1986;137(3):206–8.
Osteoporosis and osteomalacia. Schweiz Med Wochenschr. 1975 Apr 12;105(15):466–70.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.